Reversal of reduced parvalbumin neurons in hippocampus and amygdala of Angelman syndrome model mice by chronic treatment of fluoxetine
Version of Record online: 25 APR 2014
© 2014 International Society for Neurochemistry
Journal of Neurochemistry
Volume 130, Issue 3, pages 444–454, August 2014
How to Cite
J. Neurochem. (2014) 130, 444–454.
- Issue online: 18 JUL 2014
- Version of Record online: 25 APR 2014
- Accepted manuscript online: 28 MAR 2014 06:06AM EST
- Manuscript Accepted: 25 MAR 2014
- Manuscript Revised: 20 MAR 2014
- Manuscript Received: 22 JAN 2014
- Department of Biotechnology. Grant Number: BT/HRD/34/18/2008
Figure S1. Representative calbindin immunostaining in hippocampus (CA3), amygdala (BLA) and perirhinal cortex of male wild-type and AS mice.
Figure S2. Immunohistochemical staining of GAD in the cortex, hippocampus and BLA of wild-type and AS mice at P120.
Figure S3. Lower magnification images of GR and SGK immunostaining of entire hippocampus of saline and fluoxetine treated wild-type and AS mice.
Figure S4. Lower magnification images for PV immunostaining showing entire hippocampal region of saline- and fluoxetine-treated wild-type and AS mice.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.